Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine dose comparison in children undergoing adenotonsillectomy
IRCT20200325046853N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine in chronic tonsillitis and adenoiditis (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Mean arterial pressure, Mean heart rate and 11 more. Started Apr 2020; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
chronic tonsillitisadenoiditis
Beyond the preview
Go deeper on IRCT20200325046853N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200325046853N1.